Nephrocare Health Services Limited

• Nephrocare Health Services submitted audio recording of Q4 FY26 investor conference call to BSE and NSE. • The call discussed audited standalone and consolidated financial results for quarter and ye

NephroPlus reported FY26 revenue of ₹998.8 crore, a 32.2% YoY growth driven by 16.6% treatment volume increase and higher international contribution. Adjusted EBITDA grew 37.6% to ₹238.1 crore with RO

Nephrocare Health Services reported FY26 revenue of ₹998.8 crore, up 32.2% YoY, driven by 16.6% treatment growth and international expansion. Adjusted EBITDA increased 37.6% to ₹238.1 crore with margi